| Trait Information | |
| Identifier | MONDO_0002352 |
| Description | A primary or metastatic malignant neoplasm involving the larynx. The majority are carcinomas. [NCIT: C7484] | Trait category |
Other trait
|
| Synonyms |
14 synonyms
|
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000360 (PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 25,920 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000360/ScoringFiles/PGS000360.txt.gz | |
| PGS000361 (PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 87,893 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000361/ScoringFiles/PGS000361.txt.gz | |
| PGS000362 (PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Laryngeal cancer | larynx cancer | 53 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000362/ScoringFiles/PGS000362.txt.gz | |
| PGS018465 (TPMI_149_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 4 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018465/ScoringFiles/PGS018465.txt.gz | |
| PGS018466 (TPMI_149_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 939,820 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018466/ScoringFiles/PGS018466.txt.gz | |
| PGS018467 (TPMI_149_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 15,690 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018467/ScoringFiles/PGS018467.txt.gz | |
| PGS018468 (TPMI_149_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 983,777 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018468/ScoringFiles/PGS018468.txt.gz | |
| PGS018469 (TPMI_149_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cancer of larynx pharynx nasal cavities | larynx cancer | 1,000,712 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018469/ScoringFiles/PGS018469.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM001045 | PGS000360 (PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.282 [1.09, 1.508] β: 0.249 (0.0827) |
AUROC: 0.57 [0.522, 0.618] | Nagelkerke's Pseudo-R²: 0.0112 Brier score: 0.0822 Odds Ratio (OR, top 1% vs. Rest): 2.14 [0.649, 7.06] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_C32_LASSOSUM_MGI_20200608 |
| PPM001046 | PGS000361 (PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.195 [1.014, 1.408] β: 0.178 (0.0836) |
AUROC: 0.55 [0.504, 0.593] | Nagelkerke's Pseudo-R²: 0.00551 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.51 [0.382, 5.94] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_C3-LARYNX_LASSOSUM_MGI_20200608 |
| PPM001047 | PGS000362 (PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608) |
PSS000536| European Ancestry| 1,738 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of larynx | OR: 1.195 [1.023, 1.396] β: 0.178 (0.0793) |
AUROC: 0.543 [0.494, 0.59] | Nagelkerke's Pseudo-R²: 0.00609 Brier score: 0.0824 Odds Ratio (OR, top 1% vs. Rest): 1.52 [0.384, 5.98] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE149.4_UKBB-SAIGE-HRC-X149.4_PT_MGI_20200608 |
| PPM036647 | PGS018465 (TPMI_149_Lassosum2) |
PSS012373| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.72273 | R²: 0.03266 | sex, age, array, PCs 1-10 | — |
| PPM036648 | PGS018466 (TPMI_149_LDpred2) |
PSS012372| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.72128 | R²: 0.03204 | sex, age, array, PCs 1-10 | — |
| PPM036649 | PGS018467 (TPMI_149_MegaPRS) |
PSS012374| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.7201 | R²: 0.03195 | sex, age, array, PCs 1-10 | — |
| PPM036650 | PGS018468 (TPMI_149_PRS-CS) |
PSS012375| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.71945 | R²: 0.03162 | sex, age, array, PCs 1-10 | — |
| PPM036651 | PGS018469 (TPMI_149_SBayesR) |
PSS012376| East Asian Ancestry| 19,194 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of larynx pharynx nasal cavities | — | AUROC: 0.71838 | R²: 0.03124 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000536 | PheCode:149.4; ICD9CM:161.0, 161.1, 161.2, 161.3, 161.8, 161.9, 231.0, V10.21; ICD10CM:C32, C32.0, C32.1, C32.2, C32.3, C32.8, C32.9, D02.0 | — | [
|
— | European | — | MGI | — |
| PSS012372 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012373 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012374 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012375 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012376 | 146, 147, 148, 149, 160, 161, 231.0, V10.02, V10.21, V10.22,C09, C10, C11, C12, C13, C14, C30.0, C30.1, C31, C32, D02.0 | — | [ ,
45.45 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |